SARS-CoV-2: Only neutralising antibodies allow conclusions to be drawn about protection against new infections: Mutations of virus and illnesses caused by new variants are still to be expected even in a SARS-CoV-2 situation that has now become endemic. Although the population has developed specific immune responses due to previous infections and vaccinations, vaccinated and vulnerable individuals continue to contract COVID-19. In a review of the current state of knowledge, a research team led by Rudolf Valenta from MedUni Vienna concluded that only a survey of neutralising antibodies can inform us about protection against new infections. In another study, the team analysed
Further illnesses still expected from SARS-CoV-2 as seen on The Hippocratic Post.